NeoGenomics Launches PanTracer Pro for Solid Tumor Testing
The integrated testing approach combines genomic profiling with immunohistochemistry to support faster treatment decisions for advanced-stage cancer patients.
Category: Molecular Diagnostics
Molecular Diagnostics
Latest
Molecular Diagnostics
Latest
New Test Strip Detects Cancer Biomarkers at Ultra-Low Concentrations
Researchers at La Trobe University have developed a single-use test strip that detects cancer-related microRNAs in blood plasma at concentrations up to 1,000 times lower than current methods.
Molecular Diagnostics
Latest
New Stool Test Targets Specific Enzyme to Improve IBD Diagnosis
Researchers have developed a tool that measures gut-specific inflammation, potentially improving IBD diagnosis and monitoring.
Foundation Medicine Reaches 100 Approved Companion Diagnostic Indications
The precision medicine company now has 57 approvals in the US and 43 in Japan for its FoundationOne CDx and FoundationOne Liquid CDx tests.
Read More
New Partnership Aims to Expand Access to AI-Driven Cancer Genomic Testing
The collaboration combines AI-based analysis tools with a next-generation sequencing system to support labs performing tumor and liquid biopsy testing.
Read More
Qiagen Debuts Next-Gen Automated Nucleic Acid Purification Platform
The platform features enhanced speed and digital connectivity for liquid biopsy applications, with commercial release planned for mid-2026.
Read More
New ‘Ultra-Mild’ Sequencing Method Addresses DNA Methylation Testing Limitations
UMBS-seq preserves DNA integrity while maintaining accuracy for cancer biomarker detection in liquid biopsies and tissue samples.
Read More
FDA Proposes Reclassifying Oncology Nucleic Acid–Based Tests from Class III to Class II
The proposed order would shift these test systems to Class II with special controls, replacing the current PMA requirement for companion diagnostics and related oncology assays.
Read More
Optical Genome Mapping Detects Hidden Genetic Causes of Pregnancy Loss
Two studies show the advanced technique can identify chromosomal abnormalities missed by traditional genetic testing methods.
Read MoreAI Diagnostic Applications Showcased at AMP 2025 Annual Meeting
Studies demonstrate artificial intelligence achieving 93% cancer diagnostic accuracy and enabling noninvasive tumor analysis through spinal fluid testing.
Read More
SOPHiA GENETICS Partners With Element Biosciences to Integrate AI Analytics With NGS Systems
The collaboration combines SOPHiA’s DDM platform with Element’s AVITI sequencing systems to streamline genomic workflows for precision medicine research.
Read More
Security Vulnerabilities Found in Portable DNA Sequencers
Researchers identify critical flaws in Oxford Nanopore devices that could expose or alter genetic data without detection.
Read More
Countable Labs Adds RNA Module to PCR Platform for Direct RNA Quantification
The new module enables one-step reverse transcription and amplification, removing cDNA prep and supporting applications in translational research, cell and gene therapy manufacturing, and diagnostic development.
Read More
Post-Hoc Analysis Shows Pharmacogenomic Testing Speeds Depression Treatment Response
The GeneSight test results led to faster initial remission and response in patients with major depressive disorder, with benefits persisting over six months.
Read More
EazeBio Partners with UC Santa Cruz to Develop Instrument-Free Diagnostics
The collaboration will focus on creating a cortisol biosensor for stress and metabolic health testing using luminescent biosensors and AI-guided interpretation.
Read More
FDA Grants Breakthrough Device Designation for Whole Genome and Exome Tests
The designation accelerates regulatory review for GeneDx’s ExomeDx and GenomeDx testing platforms designed to diagnose rare diseases.
Read More
MyHeritage Upgrades Its Consumer DNA Tests to Whole Genome Sequencing
The upgrade leverages technology by Ultima Genomics and processing at the Gene by Gene lab.
Read More
IDT Partners with Profluent Bio to Develop AI-Designed Enzymes
The collaboration combines Profluent’s generative AI platform with IDT’s enzyme engineering and genomics expertise to accelerate development of next-generation enzymes.
Read More